Matrix metalloproteinase polymorphisms and bladder cancer risk

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Matrix metalloproteinases (MMPs) play a role in the tumor microenvironment and are implicated in bladder cancer development.
• Previous research has not explored the association between specific MMP gene polymorphisms and bladder cancer risk.

Purpose of the Study:

• To investigate the association between single nucleotide polymorphisms (SNPs) and microsatellite polymorphisms in MMP genes and bladder cancer risk.
• To analyze individual, combined, haplotype, and diplotype associations of MMP polymorphisms with bladder cancer risk.

Main Methods:

• Genotyping of 11 SNPs and one microsatellite polymorphism in MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, and MMP-12.
• Case-control study involving 560 Caucasian bladder cancer patients and 560 matched controls.
• Statistical analyses including individual, combination, haplotype, diplotype, and smoke-stratified analyses.

Main Results:

• No significant association was found between individual MMP polymorphisms and overall bladder cancer risk.
• The MMP-9 microsatellite allele (>=24 CA repeats) and MMP-12-82 GG polymorphism were associated with increased risk of invasive bladder cancer.
• Smoke-stratified analyses revealed associations between MMP polymorphisms and bladder cancer risk, particularly in light smokers. Linkage disequilibrium was observed among several MMP SNPs.

Conclusions:

• Genetic variations within the MMP gene family are associated with bladder cancer risk.
• Heavy carcinogen exposure may diminish the genetic influence of MMP polymorphisms.
• A multigenic, pathway-based approach is crucial for accurate bladder cancer risk assessment.